With the rapid development and complex challenges of chemical substances, new drug synthesis pathways are usually the most effective.246047-72-3,(1,3-Bis(2,4,6-trimethylphenyl)-2-imidazolidinylidene)dichloro(phenylmethylene)(tricyclohexylphosphine)ruthenium,as a common compound, the synthetic route is as follows.
In order to confirm by a series of compounds obtained by reaction of, reference the known method for the synthesis of beta, beta-di fluorophenyl ethylene. Furthermore, the known method of the reference (valeant literature 3, the following formula) synthesis of the (1,3-II Yl -4,5- dihydro imidazole -2-type methylene) (three ring hexyl phosphine ) methylene dichloride difluoromethane ruthenium. The following shows the results of these evaluations. These as spectrum standard, because of the above-mentioned of the internal liquid of the (mixture) is consistent with the NMR spectrum, so that the beta, beta-difluoro styrene and (1,3-II Yl -4,5- dihydro imidazole -2-type methylene) (three ring hexyl phosphine ) difluoro methylene b chlorize the generating., 246047-72-3
The synthetic route of 246047-72-3 has been constantly updated, and we look forward to future research findings.
Reference£º
Patent; Asahi Glass Co., Ltd.; YUSUKE, TAKAHIRA; (43 pag.)CN105517982; (2016); A;,
Highly efficient and robust molecular ruthenium catalysts for water oxidation
Catalysts | Special Issue : Ruthenium Catalysts – MDPI